1. Home
  2. BCRX vs CTS Comparison

BCRX vs CTS Comparison

Compare BCRX & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

SELL

Current Price

$7.63

Market Cap

2.0B

Sector

Health Care

ML Signal

SELL

Logo CTS Corporation

CTS

CTS Corporation

HOLD

Current Price

$57.15

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
CTS
Founded
1986
1896
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electrical Products
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
1995
1994

Fundamental Metrics

Financial Performance
Metric
BCRX
CTS
Price
$7.63
$57.15
Analyst Decision
Buy
Buy
Analyst Count
11
2
Target Price
$20.55
★ $73.67
AVG Volume (30 Days)
★ 5.1M
233.7K
Earning Date
11-04-2026
10-27-2026
Dividend Yield
N/A
★ 0.26%
EPS Growth
★ 381.40
15.87
EPS
N/A
★ 1.87
Revenue
$25,186,000.00
★ $541,318,000.00
Revenue This Year
N/A
$7.20
Revenue Next Year
$3.71
$7.57
P/E Ratio
★ N/A
$33.11
Revenue Growth
N/A
★ 4.95
52 Week Low
$6.23
$40.15
52 Week High
$11.22
$69.55

Technical Indicators

Market Signals
Indicator
BCRX
CTS
Relative Strength Index (RSI) 49.24 59.70
Support Level $7.95 $55.29
Resistance Level $9.22 $62.56
Average True Range (ATR) 0.33 1.94
MACD 0.08 0.84
Stochastic Oscillator 53.73 75.65

Price Performance

Historical Comparison
BCRX
CTS

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.

Share on Social Networks: